AI Engineer
ArrePath Drug Discovery
Clivora Direct Engagement: All applications and proposals are submitted directly through Clivora Connect. Clients review bids and communicate with $0 platform fees, allowing you to keep 100% of your earnings.
Benefits & Perks
ArrePath is a fully remote startup using AI to discover new classes of oral small-molecule drugs. We work in antibacterials, mycobacterial lung disease, immunology, and inflammation. Our platform has found inhibitors of six new antibacterial targets. Our team has helped discover, develop, or obtain approval for nine antibiotics. Our investors include Insight Partners, Innospark Ventures, and the Boehringer Ingelheim Venture Fund.
Ariadne is our AI scientific assistant. It is an agent with persistent memory, a web chat interface, and a single MCP gateway that brokers access to compute on AWS (Batch, Lambda, S3), external scientific APIs, and our internal data. It also includes a multi-stage literature search pipeline and an evaluation harness for measuring agent behavior. It gives our scientists natural-language access to more than 30 machine-learning models and cheminformatics tools. They use it to run
Apply & Contact
Submit your proposal directly through Clivora Connect. Zero platform commissions, direct milestone tracking, and 100% retained earnings.
Unlock Direct Company Contact & Apply
Sign in or create a free account to reveal direct company contact, external ATS links, and apply with $0 fees.
Founder Platform Guarantee
Founded by Usman Ghias at CODCrafters to free independent developers and agencies from predatory platform commissions.
About the Employer
ArrePath Drug Discovery
wellfound.comHiring for ArrePath Drug Discovery?
Register your employer profile to review inbound candidate proposals, message talent directly with $0 platform fees, and manage milestones on Clivora.
Claim this employer profile →